The store will not work correctly when cookies are disabled.
    
    
        Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts.    
    
    
        
            
                
                    Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts.                
            
            
            
            
            
            
                            
            
                     
        
            
        
     
    
    
 
 
    Copyright © 2025 by STEMCELL Technologies. All rights reserved.